Journal of the Korean Society of Food Science and Nutrition (한국식품영양과학회지)

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Hypoglycemic Effect of Culture Broth of Bacillus subtilis S10 Producing 1-Deoxynojirimycin

1-Deoxynojirimycin을 생산하는 Bacillus subtilis S10 배양액의 혈당강하 효과

  • 조용석 ((주)바이오토피아 부설생명과학연구소) ;
  • 박영식 ((주)바이오토피아 부설생명과학연구소) ;
  • 이재연 ((주)바이오토피아 부설생명과학연구소) ;
  • 강경돈 ((주)바이오토피아 부설생명과학연구소) ;
  • 황교열 ((주)바이오토피아 부설생명과학연구소) ;
  • 성수일 ((주)바이오토피아 부설생명과학연구소)
  • Published : 2008.11.28
Download PDF
⟨ Previous Next ⟩

Abstract

1-Deoxynojirimycin (DNJ) is a strong $\alpha$-glucosidase inhibitor which inhibits hyperglycemia in animals. To select the Bacillus strains highly producing DNJ, 4,000 strains were isolated from soil and grain samples. By the inhibitory activity against $\alpha$-glucosidase, nine Bacillus strains were selected and then identified by 16S rDNA sequencing. B. subtilis S10 was finally selected as the best strain for the production of DNJ. Various carbon sources and nitrogen sources in culture medium were evaluated for the highest production of DNJ. As the results, the optimized concentration of carbon source and nitrogen source was 1.0% galactose and 1.6% polypeptone and the concentration of DNJ produced was 0.75 g/L. The effect of culture supernatant of B. subtilis S10 on lowering blood glucose level was investigated in streptozotocin (STZ)-induced diabetic mice model. Mice were randomly assigned to control group (saline) and three test groups such as acarbose group, silkworm powder group and B. subtilis S10 group. After eight-week oral feeding, blood glucose levels of the B. subtilis S10 and silkworm powder groups were respectively $209.1{\pm}19.6\;mg/dL$ (59.1%) and $208.6{\pm}39.8\;mg/dL$ (59.0%) lower than $510{\pm}10\;mg/dL$ of the control group. These results indicated that the culture supernatant of B. subtilis S10 was able to reduce the blood glucose level in STZ-induced diabetic mice.

본 연구는 $\alpha$-glucosidase의 강력한 효소저해제인 1-deoxynojirimycin(DNJ)을 고효율로 생산하는 균주의 선발 및 동정, 배양최적화 및 균 배양액의 혈당강하효과 등에 관하여 조사하였다. 먼저 토양으로부터 $\alpha$-glucosidase에 대해 강력한 저해능을 나타내는 9균주를 대상으로 이 중에서 DNJ 생산성이 가장 우수한 한 개 균주를 최종 선발하였고, 이 균주를 16S rDNA 염기서열분석으로 균주동정을 하여 Bacillus subtilis S10이라 명명하였다. 본 균주의 배양액을 이온교환수지법(Amberlyst 15 $H^+$ form, Dowex $1{\times}2$-100 $OH^-$ form, Amberlite CG-50 $NH_3^+$ form)에 의해 DNJ를 정제하고, 정제된 DNJ를 LC-MS로 분석한 결과 표준 DNJ와 동일한 물질임을 확인하였다. DNJ 대량생산을 위한 S10균주의 배양 최적탄소원 및 최적질소원과 이들의 최적농도를 조사한 결과 각각 1% galactose, 1.6% polypeptone임이 밝혀졌으며, 확립된 최적화 조건에서의 DNJ 생산량은 0.75 g/L이었다. 고혈당 유도 마우스를 대상으로 각종 혈당강하제의 효과를 알아보기 위해 혈당치를 비교한 결과 무처리구의 혈당치 $510{\pm}10.9\;mg/dL$에 비해 acarbose 처리구는 $139.4{\pm}33.1\;mg/dL$, 누에분말 처리구는 $209.1{\pm}19.6\;mg/dL$, 그리고 S10 균주 배양액 처리구는 $208.6{\pm}39.8\;mg/dL$로써 무처리구에 비해 각각 72.7%, 59.0%, 그리고 59.1%의 혈당 억제율을 나타냈다. 이상의 연구결과 S10균주 배양액은 누에분말과 같은 수준의 고혈당 억제 및 완화효과가 있음이 확인되었으며 향후 S10균주의 대량생산을 통해 식후혈당조절을 위한 건 강기능식품 개발이 기대된다 하겠다.

Keywords

References

  1. Schmidt DD, Frommer W, Muller L, Truscheit E. 1979. Glucosidase-inhibitoren aus Bazillen. Naturwissenshaften 66: 584-585 https://doi.org/10.1007/BF00368825
  2. Yagi M, Kouno T, Aoyagi Y, Murai H. 1976. The structure of moranoline a piperidine alkaloid from Morus species. Nippon Nogeikagaku Kaish 50: 571-572 https://doi.org/10.1271/nogeikagaku1924.50.11_571
  3. Bischoff H. 1995. The mechanism of a-glucosidase inhibition in the management of diabetes. Chin Invest Med 18: 303-311
  4. Lembcke B, Folsch UR, Creutzfeldt W. 1985. Effect of 1-deoxynojirimycin derivatives on small intestinal disaccharidase activities and on active transport in vitro. Digestion 31: 120-127 https://doi.org/10.1159/000199188
  5. Asano N, Nash RJ, Molyneux RJ, George WJ. 2000. Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application. Tetrahedron: Asymmetry 11: 1645-1680 https://doi.org/10.1016/S0957-4166(00)00113-0
  6. Breitmeier D, Gunther S, Heymann H. 1997. Acarbose and 1-deoxynojirimycin inhibit maltose and maltooligosaccharide hydrolysis of human small intestinal glucoamylase-maltase in two different substrate-induced modes. Arch Biochem Biophys 346: 7-14 https://doi.org/10.1006/abbi.1997.0274
  7. Park SW, Song YD, Lee EJ, Lim SK, Kim KR, Lee HC, Huh KB, Chung YS. 1994. Effect of acarbose in NIDDM insufficiently treated with diet alone. Korean Diabetes J 18: 263-269
  8. Watanabe K, Uchino H, Ohmura C, Tanaka Y, Onuma T, Kawamori R. 2004. Different effects of two a-glucosidase inhibitors, acarbose and voglibose, on serum 1,5-anhydroglucitol (1,5AG) level. J Diabetes Complications 18: 183-186 https://doi.org/10.1016/S1056-8727(03)00055-2
  9. Asano N, Kato A, Kizu H, Matsui KM, Watson A, Nash RJ. 1996. Calystegine $B_4$, a novel trehalase inhibitor from Scopolia japonica. Carbohydr Res 293: 195-382 https://doi.org/10.1016/0008-6215(96)00204-2
  10. Aasno N, Yamashita T, Yasuda K, Ikeda K. 2001. Polyhydroxylated alkaloids isolated from mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.). J Agric Food Chem 49: 4208-4213 https://doi.org/10.1021/jf010567e
  11. Aasno N, Nishida M, Miyauchi M, Ikeda K. 2000. Polyhydroxylated pyrrolidine and piperidine alkaloids from Adenophora triphylla var. japonica (Campanulaceae). Phytochemistry 53: 397-382 https://doi.org/10.1016/S0031-9422(99)00555-5
  12. Evans SV, Fellow LE, Shing TKM, Fleet GWJ. 1985. Glycosidase inhibition by plant alkaloids which are structural analogues of monosaccharides. Phytochemistry 24: 1953-1955 https://doi.org/10.1016/S0031-9422(00)83099-X
  13. Murao S, Miyata S. 1980. Isolation and characterization of a new trehalase inhibitor, S-GI. Agric Biol Chem 44: 219-221 https://doi.org/10.1271/bbb1961.44.219
  14. Yamada H, Oya I, Nagai T. 1993. Screening of a-glucosidase II inhibitor from Chinese herbs and its application on the quality control of mulberry bark. Shoyakugaku Zasshi 47: 47-55
  15. Ezure Y, Maruo S, Miyazaki K, Kawamata M. 1985. Moranoline (1-deoxynojirimycin) fermentation and its improvement. Agric Biol chem 49: 1119-1125 https://doi.org/10.1271/bbb1961.49.1119
  16. Hardick DJ, Hutchinson DW, Trew SJ, Wellington EMH. 1992. Glucose is a precursor of 1-deoxynojirimycin and 1-deoxymannonojirimycin in Streptomyces subrutilus. Tetrahedron 48: 6285-6296 https://doi.org/10.1016/S0040-4020(01)88220-X
  17. Hardick DJ, Hutchinson DW. 1993. The biosynthesis of 1-deoxynojirimycin in Bacillus subtilis var niger. Biochemistry 49: 6707-6716 https://doi.org/10.1016/S0040-4020(01)81840-8
  18. Paek NS, Kang DS, Choi YJ, Lee JJ, Kim TH, Kim KW. 1997. Production of 1-deoxynojirimycin by Streptomyces sp. SID9135. J Microbiol Biochnol 7: 262-266
  19. Scofield AM, Fellow LE, Nash RJ, Fleet GWJ. 1986. Inhibition of mammalian digestive disaccharidases by polyhydroxy alkaloids. Life Sci 39: 29-32 https://doi.org/10.1016/0024-3205(86)90046-9
  20. Werner F, Lutz M, Delf S, Krause HP. 1981. Inhibitors, obtained from bacilli, for glycoside hydrolases. US Patent 4307194
  21. Kim JW, Kim SU, Lee HS. 2003. Determination of 1-deoxynojirimycin in Morus alba L. leaves by derivatization with 9-fluorenylmethyl chloroformate followed by reversedphase high-performance liquid chromatography. Chromatography 1002: 93-99 https://doi.org/10.1016/S0021-9673(03)00728-3
  22. Kim MS, Choue RW, Chung SH, Koo SJ. 1998. Blood glucose lowering effects of mulberry leaves and silkworm extracts on mice fed with high-carbohydrate diet. Korean J Nutrition 31: 117-125
  23. Kim SH, Kim KS, Lee JH, Chung EK, Park YS, Park YJ, Lee HY. 1997. Comparison of glucose-lowering activity of the extracts from Kangwon-do mountain mulberry leaves (Mori Folium) and silk worm. Kor J Appl Microbiol Biotechnol 25: 391-395
  24. Lee HS, Chung KS, Kim SY, Ryu KS, Lee WC. 1998. Effect of several sericultural products on blood glucose lowering for alloxan-induced hyperglycemic mice. Korean J Seric Sci 40: 38-42

Cited by

  1. Production of the α-glycosidase inhibitor 1-deoxynojirimycin from Bacillus species vol.138, pp.1, 2013, https://doi.org/10.1016/j.foodchem.2012.11.012
  2. Biological Activity and Biochemical Properties of Silkworm (Bombyx mori L.) Powder Fermented with Bacillus subtilis and Aspergillus kawachii vol.21, pp.1, 2011, https://doi.org/10.5352/JLS.2011.21.1.81
  3. Enhanced production of α-glucosidase inhibitor by a newly isolated strain of Bacillus subtilis B2 using response surface methodology vol.91, pp.3, 2013, https://doi.org/10.1016/j.fbp.2012.09.010
  4. Decreased formation of branched-chain short fatty acids in Bacillus amyloliquefaciens by metabolic engineering vol.39, pp.4, 2017, https://doi.org/10.1007/s10529-016-2270-5
  5. Protein Analysis of Bacillus subtilis MORI 3K-85 with Reference to the Biosynthesis of 1-Deoxynojirimycin vol.26, pp.6, 2011, https://doi.org/10.7841/ksbbj.2011.26.6.517
  6. Inhibition of Adipogenesis in 3T3-Ll Adipocytes with Water and Ethanol Extracts of Cudrania tricuspidata Leaves vol.18, pp.2, 2011, https://doi.org/10.11002/kjfp.2011.18.2.244
  7. Physiological Activities of Korean Traditional Soybean-Fermented Royal Court Soy Sauces, Gungjungjang vol.41, pp.2, 2012, https://doi.org/10.3746/jkfn.2012.41.2.149
  8. Biosynthesis of α-Glucosidase Inhibitors by a Newly Isolated Bacterium, Paenibacillus sp. TKU042 and Its Effect on Reducing Plasma Glucose in a Mouse Model vol.18, pp.4, 2017, https://doi.org/10.3390/ijms18040700
  9. Identification of the genes involved in 1-deoxynojirimycin synthesis in Bacillus subtilis MORI 3K-85 vol.49, pp.3, 2011, https://doi.org/10.1007/s12275-011-1238-3
  10. Quantitative Analysis of 1-deoxynojirimycin in Mulberry Leaves vol.51, pp.1, 2013, https://doi.org/10.7852/jses.2013.51.1.20
  11. Anti-diabetic effect of the soybean extract fermented by Bacillus subtilis MORI in db/db mice vol.21, pp.6, 2012, https://doi.org/10.1007/s10068-012-0222-y
  12. Utilization of Fishery Processing By-Product Squid Pens for α-Glucosidase Inhibitors Production by Paenibacillus sp. vol.15, pp.9, 2017, https://doi.org/10.3390/md15090274
  13. Reclamation of Marine Chitinous Materials for the Production of α-Glucosidase Inhibitors via Microbial Conversion vol.15, pp.11, 2017, https://doi.org/10.3390/md15110350
  14. Culture Optimization Strategy for 1-Deoxynojirimycin-producing Bacillus methylotrophicus K26 Isolated from Korean Fermented Soybean Paste, Doenjang vol.23, pp.4, 2018, https://doi.org/10.1007/s12257-018-0159-y
  15. Improved production of 1-deoxynojirymicin in Escherichia coli through metabolic engineering vol.34, pp.6, 2018, https://doi.org/10.1007/s11274-018-2462-3
  16. Anti-α-Glucosidase Activity by a Protease from Bacillus licheniformis vol.24, pp.4, 2019, https://doi.org/10.3390/molecules24040691
  17. Isolation of the Putative Biosynthetic Gene Cluster of 1-Deoxynojirimycin by Bacillus amyloliquefaciens 140N, Its Production and Application to the Fermentation of Soybean Paste vol.77, pp.2, 2008, https://doi.org/10.1271/bbb.120753
  18. 1-Deoxynojirimycin Isolated from a Bacillus subtilis Stimulates Adiponectin and GLUT4 Expressions in 3T3-L1 Adipocytes vol.23, pp.5, 2008, https://doi.org/10.4014/jmb.1209.09043
  19. Optimization of culture conditions of Bacillus subtilis with α-glucosidase inhibitory activity vol.33, pp.1, 2016, https://doi.org/10.7852/ijie.2016.33.1.24
  20. Bioprocessing shrimp shells for rat intestinal α-glucosidase inhibitor and its effect on reducing blood glucose in a mouse model vol.45, pp.10, 2008, https://doi.org/10.1007/s11164-019-03869-2